Log in

Introduction to Cannabis as a Treatment for Psychological Disease

  • 05 Nov 2021
  • 10:00 AM - 1:00 PM
  • Virtual

Registration

  • Participants will receive 3 CE credits.
  • This webinar is discounted for DCPA students. Please use your student email to register. Continuing education credits are not issued under this category.
  • Continuing education credits are not issued under this category.
  • Registrants will receive 3 continuing education credits.
  • Please use your student email to register. Continuing education credits are not issued under this category.

Register


Event Description: 

Cannabis has been used as a medicine for thousands of years for the treatment of a bevy of neurological and mental health conditions. This presentation will discuss the benefits of medical-cannabis and provide guidance to healthcare professionals interested in exploring the possibility of recommending medical cannabis to their patients with the appropriate qualifying conditions. Dr. Lehfeldt will share the latest research on the beneficial effects of cannabis and its ability to treat a range of neuropsychiatric conditions in an effort to better understand medical cannabis, its applications, and its safety. Dr. Lehfeldt will review treatment modalities and future pharmacological topics, while also discussing the limitations of research in the cannabis sphere.

3 Continuing Education Credits are available

Learning Objectives:

Participants will be able to:

 1) Learn the history of cannabis, including the prohibition of cannabis in America which lead to federal illegality.  

2) Learn about the physiology of cannabis including retrograde neurotransmission in the endocannabinoid system and how it differs from canonical neurotransmission.

3) Explain the different mechanisms of delivery of cannabis-based medicine, learn basic pharmacokinetics including the bioavailability of different phytocannabinoids and the onset of action and duration of different cannabis formulations.

4)  Discuss the psychiatric qualifying conditions with a focus on current research on phytocannabinoids and pain, PTSD, anxiety, and psychosis.

Presenter Information:  Paloma  L. Lehfeldt, MD, MA



Dr. Paloma Lehfeldt is a lifelong cannabis student and advocate who serves as the Director of Medical Education for Vireo Health- a physician-led and science-driven cannabis company.   Dr. Lehfeldt brings to Vireo more than ten years of experience in psychiatric research, community outreach, and teaching. She has expertise in neuroscience with a keen interest in mental health and the endocannabinoid system.

At Vireo, Dr. Lehfeldt is the direct line of communication with healthcare providers and organizes outreach events, conferences, continuing education, and lectures for both providers and patients.  Additionally, Paloma supports cannabis clinical research at Vireo Health which includes a 3.8 M dollar NIH grant focused on opioid reduction in chronic pain medical cannabis patients.  Dr. Lehfeldt also co-chairs  Vireo Health's Diversity, Equity, and Inclusion Council where she leads expungement efforts across the country.  She is passionate about the use of cannabis as medicine and cannabis health equity and looks forward to advocating its healing properties throughout her career

Disclaimer: There is no conflict of interest or commercial support for this program.

*DCPA Refund Policy:   Refund requests more than one week prior to the webinar should be sent to info@dcpsychology.org  If the request comes within one week of the webinar, only credit will be offered.

Our Mission

The D.C. Psychological Association (DCPA) works to advance psychology as a source for the promotion of public welfare and human dignity.

Become a member

Join DCPA as a professional, student, or retired member.
Powered by Wild Apricot Membership Software